Indicated for patients targeting longevity, neurological performance, or recovery from metabolic decline
The structural modifications incorporated into CJC-1295 include D-alanine at position 2 to enhance resistance to enzymatic degradation, glutamine at position 8 to reduce asparagine rearrangement and prevent amide hydrolysis to aspartic acid, alanine at position 15 to enhance bioactivity, and leucine at position 27 to prevent methionine oxidation
Specifically formulated for major tendon tears, ligament ruptures, complex fractures, and extensive soft tissue damage requiring maximum regenerative support
Reduce Neuroinflammatory and Oxidative Burden The program uses nutrition, vitamin D, omega-3 fats, antioxidants and other nutraceuticals selected from laboratory findings and clinical context
Caspase-1-dependent pyroptosis converts alphaSMA(+) CAFs into collagen-III(high) iCAFs to fuel chemoresistant cancer stem cells